• FITC-Concanavalin A (ConA) Conjugate: Technical Lab Use Guid

  2026-08-03

  FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of α-D-glucose and α-D-mannose on cell surfaces, supporting workflows in immunofluorescence, flow cytometry, and glycobiology. It is not suitable for non-carbohydrate-binding assays or protocols outside its defined stability and storage parameters. For optimal results, users must adhere closely to product specifications and established best practices.

• Technical Guidelines for TBST (Tris-Buffered Saline and Twee

  2026-08-03

  TBST (Tris-Buffered Saline and Tween 20) addresses nonspecific binding and high background in antibody-based assays, particularly Western blotting and immunohistochemistry. Its isotonic formulation with non-ionic detergent supports reproducibility in signal detection but should not be used where detergent sensitivity is a concern.

• HRP Rabbit Anti-Goat IgG (H+L) Antibody: Next-Gen Signal Amp

  2026-08-02

  Explore how the HRP Rabbit Anti-Goat IgG (H+L) Antibody enables next-level sensitivity in immunodetection of goat primary antibodies. This article offers a unique, protocol-driven perspective on assay optimization and translational research impact.

• Biomimetic Chromatography Advances Pulmonary Permeability Mo

  2026-08-01

  The reference study introduces and rigorously evaluates biomimetic open tubular capillary electrochromatography (OT-CEC) and immobilised artificial membrane liquid chromatography (IAM-LC), both coupled with mass spectrometry, for modeling lung drug permeability. These MS-compatible techniques enable high-throughput, robust assessment of pharmaceutical absorption relevant to respiratory disease research and anti-inflammatory corticosteroid development.

• CFDA SE Cell Tracer Kit: Technical Guidance for Stable Cell

  2026-07-31

  The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit provides researchers with a robust, covalent fluorescent labeling method for long-term cell tracing in both in vitro and in vivo settings. It is suited for applications like cell lineage and proliferation studies where stable, persistent cell marking is required, but is not appropriate for workflows needing reversible or short-term cell labeling.

• Ruxolitinib Phosphate: Mitochondrial Dynamics and JAK/STAT M

  2026-07-31

  Explore the unique dual role of Ruxolitinib phosphate (INCB018424) in modulating JAK/STAT signaling and mitochondrial fission, with implications for cancer and autoimmune disease research. This article provides in-depth mechanistic insights and assay guidance for translational scientists.

• SB202190: Advancing p38 MAPK Inhibition in Translational Res

  2026-07-30

  Explore how SB202190 (FHPI) enables next-generation inflammation and cancer research through precise p38 MAPK pathway modulation, practical protocol guidance, and strategic insights for translational researchers.

• Imatinib Hydrochloride: Dual-Action Kinase Inhibition in Can

  2026-07-30

  Explore the advanced dual-action mechanisms of Imatinib hydrochloride in cancer research, including its role as a tyrosine kinase inhibitor and its impact on kinase dephosphorylation. Discover how this unique perspective informs experimental design and therapeutic strategies.

• 3X FLAG Peptide: Mechanistic Leverage for Translational Disc

  2026-07-29

  Explore how the 3X (DYKDDDDK) Peptide advances affinity purification, immunodetection, and protein crystallization in high-impact translational research. This thought-leadership article synthesizes mechanistic insight and workflow strategy, contextualizing the peptide’s value in emerging immunology and structural biology, with direct application to studies of tumor immune regulation and PD-L1 signaling.

• Cyclic di-GMP: Applied Protocols for Biofilm & Immune Resear

  2026-07-29

  Cyclic di-GMP bridges bacterial biofilm investigation and STING-driven immune modulation, enabling cross-domain breakthroughs. Discover tailored protocol parameters, troubleshooting strategies, and actionable insights that maximize APExBIO’s high-purity cyclic di-GMP in both microbiological and immunological studies.

• Thymosin-β4 Drives Angiogenesis via Notch/NF-κB in Limb Isch

  2026-07-28

  Lv et al. (2020) demonstrate that Thymosin-β4 (Tβ4) stimulates angiogenesis in a mouse model of critical limb ischemia by modulating the Notch and NF-κB pathways. Their findings clarify mechanistic links between Tβ4, endothelial cell function, and vascular remodeling, highlighting targets for therapeutic intervention in ischemic vascular disease.

• IL-17A as a Prognostic Marker in Maternal GBS Colonization

  2026-07-28

  This study identifies maternal IL-17A as a critical prognostic biomarker for assessing the risk of neonatal invasive disease in pregnancies complicated by Group B Streptococcus (GBS) colonization. By integrating cytokine profiling and ex vivo TLR1/2 activation assays, the research advances risk stratification and informs translational approaches to maternal-neonatal infectious disease.

• Clodronate Liposomes: Mechanistic Precision for Translationa

  2026-07-27

  Explore the mechanistic underpinnings and strategic application of Clodronate Liposomes for in vivo macrophage depletion. This thought-leadership article synthesizes cutting-edge data, clarifies best practices for experimental design, and maps the translational landscape for immune modulation, highlighting tissue-specific, apoptosis-driven approaches and referencing advanced single-cell studies. See how APExBIO's solution empowers reproducible research and next-generation immunological insight.

• ONX-0914 (PR-957): Immunoproteasome Inhibition for Translati

  2026-07-27

  This article offers a strategic and mechanistic exploration of ONX-0914 (PR-957), a selective immunoproteasome LMP7 inhibitor, guiding translational researchers through its biological rationale, experimental applications, and future outlook in autoimmune and CNS disease modeling. Key mechanistic insights and protocol parameters are provided, along with a critical synthesis of recent literature and workflow innovations.

• Cyclophosphamide: Applied Workflows in Cancer and Immune Res

  2026-07-26

  Cyclophosphamide stands out as a versatile alkylating chemotherapeutic agent, enabling precise apoptosis induction and immunomodulation across cancer and transplantation models. This guide delivers protocol design, troubleshooting insights, and comparative workflow enhancements for reproducible, high-impact research outcomes.

16175 records 1/1079 page Next 12345 下5页 Last page